To explore the potential mechanisms of the downregulation of SPRED1 in AML, we performed FISH analysis of SPRED1 in 48 AML patients, who had decreased SPRED1 mRNA expression comparing to the healthy control. The gene discussed is SPRED1; the disease is acute myeloid leukemia.